Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The firm focuses on the development of its drug delivery system, QuickStrip, which is capable of releasing into the blood stream a pharmaceuticals, emulsified oils and over-the-counter without being degraded by first pass metabolism in the liver. It also offers product innovation, production and consultation to the pharmaceutical and healthcare manufacturing industry. The company was founded on February 27, 2008 and is headquartered in Burlington, Canada.
CSE